AMGEN INC Non-operating Income/Expense 2007-2026 | AMGN
Beta
What is AMGEN INC's current non-operating income/expense?
AMGEN INC (AMGN) annual non-operating income/expense for 2025 was $2.65B, a 423.91% increase from 2024. AMGEN INC non-operating income/expense for the quarter ending March 31, 2026 was $75.0M.
What was AMGEN INC's non-operating income/expense in 2024?
AMGEN INC annual non-operating income/expense for 2024 was $506.0M, a 82.14% decline from 2023.
What was AMGEN INC's non-operating income/expense in 2023?
AMGEN INC annual non-operating income/expense for 2023 was $2.83B, a 448.03% increase from 2022.
What is AMGEN INC's 5-year non-operating income/expense CAGR?
AMGEN INC non-operating income/expense grew at a compound annual growth rate (CAGR) of 59.60% from FY2020 to FY2025, going from $256.0M to $2.65B over 5 years.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+59.6%
FY2020
$256.0M
→
FY2025
$2.65B
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.65B | +423.9% | 10-K |
| FY2024 | $506.0M | -82.1% | 10-K |
| FY2023 | $2.83B | +448.0% | 10-K |
| FY2022 | $-814.0M | -414.3% | 10-K |
| FY2021 | $259.0M | +1.2% | 10-K |
| FY2020 | $256.0M | -66.0% | 10-K |
| FY2019 | $753.0M | +11.7% | 10-K |
| FY2018 | $674.0M | -27.4% | 10-K |
| FY2017 | $928.0M | +47.5% | 10-K |
| FY2016 | $629.0M | +4.3% | 10-K |
| FY2015 | $603.0M | +29.7% | 10-K |
| FY2014 | $465.0M | +10.7% | 10-K |
| FY2013 | $420.0M | -13.4% | 10-K |
| FY2012 | $485.0M | +8.3% | 10-K |
| FY2011 | $448.0M | +19.1% | 10-K |
| FY2010 | $376.0M | +36.2% | 10-K |
| FY2009 | $276.0M | -21.6% | 10-K |
| FY2008 | $352.0M | +13.9% | 10-K |
| FY2007 | $309.0M | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →